Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Covid-19    crawled date : 2020 - 12 - 03    save search

Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
Published: 2020-06-15 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -3.0% H: 9.73% C: 8.85%

covid new ceo ceo leo covid-19 program
Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed
Published: 2020-06-26 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 83.55% H: 24.46% C: -30.03%

covid vaccine covid-19
Vaxart Announces IND Filed for COVID-19 Vaccine
Published: 2020-08-10 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 4.57% H: 2.6% C: -2.24%

covid vaccine covid-19
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Published: 2020-09-08 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 12.37% H: 2.71% C: -13.0%

covid vaccine preclinical response covid-19 pre-clinical
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Published: 2020-09-14 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 20.38% H: 32.76% C: 21.94%

covid fda clearance fda vaccine covid-19 application clearance
Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
Published: 2020-10-14 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 2.1% C: -9.33%

covid positive vaccine covid-19
Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine
Published: 2020-11-12 (Crawled : 09:36) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 12.7% H: 8.86% C: 2.31%

covid vaccine covid-19
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.